Masaryk University

Publication Records

česky | in English

Filter publications

    2024

    1. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
      NAVRKALOVÁ, Veronika, Karla PLEVOVÁ, Lenka RADOVÁ, Jakub Paweł PORC, Karol PÁL, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Jana KOTAŠKOVÁ and Šárka POSPÍŠILOVÁ. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, vol. 204, No 1, p. 240-249. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19191.
      URL
      RIV: Article in a journal. English. United States of America.
      Navrkalová, Veronika (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Porc, Jakub Paweł (616 Poland, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymphocytic leukaemia; clonal evolution; genomic aberration; integrative NGS testing; prognosis
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 2/4/2024 14:17.
      More: https://is.muni.cz/publication/2372237/en

    2023

    1. Cílená terapie a imunoterapie u chronické lymfocytární leukemie (Targeted therapy and immunotherapy in chronic lymphocytic leukemia)
      BEZDĚKOVÁ, Lucie, Tomáš ARPÁŠ and Anna PANOVSKÁ. Cílená terapie a imunoterapie u chronické lymfocytární leukemie (Targeted therapy and immunotherapy in chronic lymphocytic leukemia). Acta medicinae. Brno: ERA média, s.r.o., 2023, vol. 2023, 12-13, p. 119-122. ISSN 1805-398X.
      URL
      Name (in English): Targeted therapy and immunotherapy in chronic lymphocytic leukemia
      RIV/00216224:14110/23:00133221 Article in a journal. Czech. Czech Republic.
      Bezděková, Lucie (203 Czech Republic, belonging to the institution) -- Arpáš, Tomáš (703 Slovakia, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; targeted therapy; BTK inhibitor; Bcl-2 inhibitor; PI3K inhibitor; immunotherapy
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/1/2024 13:32.
      More: https://is.muni.cz/publication/2365598/en
    2. Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Jakub Paweł PORC, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Kamila STRÁNSKÁ, Marcela ŽENATOVÁ, Boris TICHÝ, Nicolas BLAVET, Anna PANOVSKÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Clonal competition and disrupted molecular processes in chronic lymphocytic leukemia. In XXVIIth Biochemistry congress. 2023. ISBN 978-80-8240-048-2.
      URL
      RIV/00216224:14740/23:00131784 Conference abstract. English. Slovakia.
      Závacká, Kristýna (203 Czech Republic, belonging to the institution) -- Tauš, Petr (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Porc, Jakub Paweł (616 Poland, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Stránská, Kamila (203 Czech Republic, belonging to the institution) -- Ženatová, Marcela (203 Czech Republic, belonging to the institution) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Blavet, Nicolas (250 France, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution)
      Keywords in English: Chronic lymphocytic leukemia; TP53 gene;
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 24/3/2024 12:54.
      More: https://is.muni.cz/publication/2317919/en
    3. Complex cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid mylignancies with a focus on targeted analysis of the MECOM gene.
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Complex cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid mylignancies with a focus on targeted analysis of the MECOM gene. In EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms, Budapest, Maďarsko. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 5/1/2024 11:55.
      More: https://is.muni.cz/publication/2356401/en
    4. Cytogenetický screening pacientů s chronickou lymfocytární leukémií léčených inhibitorem Brutonovy tyrozinkinázy.
      ONDROUŠKOVÁ, Eva, Terezie FITZOVÁ, Lenka BRYJOVÁ, Petra ŠMUHAŘOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Marie JAROŠOVÁ. Cytogenetický screening pacientů s chronickou lymfocytární leukémií léčených inhibitorem Brutonovy tyrozinkinázy. In 56. Výroční cytogenomická konference, Ostrava. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 5/1/2024 12:04.
      More: https://is.muni.cz/publication/2356331/en
    5. Dynamics of genomic aberrations in relation to disease activity in untreated patients with chronic lymphocytic leukemia.
      NAVRKALOVÁ, Veronika, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Tomáš REIGL, Jakub Paweł PORC, Lenka RADOVÁ, Anna PANOVSKÁ and Šárka POSPÍŠILOVÁ. Dynamics of genomic aberrations in relation to disease activity in untreated patients with chronic lymphocytic leukemia. In 23. Pražské hematologické dny, Praha. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 1/2/2023 10:41.
      More: https://is.muni.cz/publication/2251886/en
    6. FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.
      ONDRIŠOVÁ, Laura, Václav ŠEDA, Giorgia CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Daniel FILIP, Pedro FARIA ZENI, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, Martin ŠIMKOVIČ, Filip VRBACKÝ, Daniel LYSÁK, Stacey M. FERNANDEZ, MS. DAVIDS, Alba MAIQUES-DIAZ, Stella CHARALAMPOPOULOU, Jose I. MARTIN-SUBERO, Jennifer R. BROWN, Michael DOUBEK, Francesco FORCONI, Jiří MAYER and Marek MRÁZ. FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy. In EHA 2023 in HemaSphere (2023). 2023. ISSN 2572-9241.
      URL
      RIV/00216224:14740/23:00131046 Conference abstract. English. Germany.
      Ondrišová, Laura (703 Slovakia, belonging to the institution) -- Šeda, Václav (203 Czech Republic, belonging to the institution) -- Hlaváč, Kryštof (203 Czech Republic, belonging to the institution) -- Košťálová, Lenka (203 Czech Republic, belonging to the institution) -- Filip, Daniel (703 Slovakia, belonging to the institution) -- Faria Zeni, Pedro (76 Brazil, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Lysák, Daniel (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: BCR inhibitors; BTK inhibitors; CCL; BCR; FoxO1/Rictor
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 24/3/2024 11:56.
      More: https://is.muni.cz/publication/2293204/en
    7. Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.
      HLAVÁČ, Kryštof, Laura ONDRIŠOVÁ, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro FARIA ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. ŠIMKOVIČ, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, MS. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, I. MARTIN-SUBERO, JR. BROWN, Michael DOUBEK, Francesco FORCONI, Jiří MAYER and Marek MRÁZ. Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia. In Czech Annual Cancer Research Meeting, Olomouc. 2023.
      URL
      RIV/00216224:14740/23:00132964 Conference abstract. English. Czech Republic.
      Hlaváč, Kryštof (203 Czech Republic) -- Ondrišová, Laura (703 Slovakia, belonging to the institution) -- Šeda, Václav (203 Czech Republic, belonging to the institution) -- Košťálová, Lenka (203 Czech Republic, belonging to the institution) -- Mladonická Pavlasová, Gabriela (203 Czech Republic, belonging to the institution) -- Filip, Daniel (703 Slovakia, belonging to the institution) -- Faria Zeni, Pedro (76 Brazil, belonging to the institution) -- Oppelt, Jan (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Lysák, Daniel (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: BCR inhibitors; CLL; PI3K-Akt activation
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 24/3/2024 21:37.
      More: https://is.muni.cz/publication/2359957/en
    8. FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.
      ONDRIŠOVÁ, Laura, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro FARIA ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. SIMKOVIC, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, MS. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, JI. MARTIN-SUBERO, JR. BROWN, Michael DOUBEK, F. FORCONI, Jiří MAYER and Marek MRÁZ. FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy. In ICML, Švýcarsko, Lugano. 2023.
      URL
      RIV/00216224:14740/23:00131268 Conference abstract. English. Switzerland.
      Ondrišová, Laura (703 Slovakia, belonging to the institution) -- Šeda, Václav (203 Czech Republic, belonging to the institution) -- Hoferková, Eva (203 Czech Republic, belonging to the institution) -- Hlaváč, Kryštof (203 Czech Republic, belonging to the institution) -- Košťálová, Lenka (203 Czech Republic, belonging to the institution) -- Mladonická Pavlasová, Gabriela (203 Czech Republic, belonging to the institution) -- Filip, Daniel (703 Slovakia, belonging to the institution) -- Faria Zeni, Pedro (76 Brazil, belonging to the institution) -- Oppelt, Jan (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Lysák, Daniel (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: BCR inhibitors; CLL; PI3K‐Akt activation
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 24/3/2024 21:16.
      More: https://is.muni.cz/publication/2298211/en
    9. Chronická lymfocytární leukemie (Chronic lymphocytic leukaemia)
      PANOVSKÁ, Anna, Yvona BRYCHTOVÁ and Michael DOUBEK. Chronická lymfocytární leukemie (Chronic lymphocytic leukaemia). Online. In Tomášem Büchler. Klinická onkologie. 1st ed. Praha: Maxdorf, 2023, p. 353-355. Jessenius. ISBN 978-80-7345-758-7.
      URL
      Name (in English): Chronic lymphocytic leukaemia
      RIV/00216224:14110/23:00131659 Chapter(s) of a specialized book. Czech. Czech Republic.
      Panovská, Anna (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukaemia
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/3/2024 12:38.
      More: https://is.muni.cz/publication/2309917/en
    10. Jak klinicky interpretovat výsledky TP53 analýz u chronické lymfocytární leukemie v kontextu dostupných terapeutických režimů (How to clinically interpret the results of TP53 analyses in chronic lymphocytic leukaemia in the context of available therapeutic regimens)
      KUNT VONKOVÁ, Barbara, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Karol PÁL, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Jak klinicky interpretovat výsledky TP53 analýz u chronické lymfocytární leukemie v kontextu dostupných terapeutických režimů (How to clinically interpret the results of TP53 analyses in chronic lymphocytic leukaemia in the context of available therapeutic regimens). Transfuze a Hematologie Dnes. Praha: Ceska Lekarska Spolecnost J.E. Purkyne/Czech Medical Association, 2023, vol. 29, No 2, p. 117-123. ISSN 1213-5763. Available from: https://dx.doi.org/10.48095/cctahd2023prolekare.cz11.
      URL
      Name in Czech: Jak klinicky interpretovat výsledky TP53 analýz u chronické lymfocytární leukemie v kontextu dostupných terapeutických režimů
      Name (in English): How to clinically interpret the results of TP53 analyses in chronic lymphocytic leukaemia in the context of available therapeutic regimens
      RIV/00216224:14740/23:00130995 Article in a journal. Czech. Czech Republic.
      Kunt Vonková, Barbara (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymphocytic leukaemia; TP53 mutations; clonal evolution; FCR
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 4/4/2024 21:35.
      More: https://is.muni.cz/publication/2292599/en
    11. Kombinace obinutuzumab a venetoklax v léčbě chronické lymfocytární leukemie (The combination of obinutuzumab and venetoclax in the treatment of chronic lymphocytic leukemia)
      ARPÁŠ, Tomáš, Adéla PRCHLÍKOVÁ and Anna PANOVSKÁ. Kombinace obinutuzumab a venetoklax v léčbě chronické lymfocytární leukemie (The combination of obinutuzumab and venetoclax in the treatment of chronic lymphocytic leukemia). Farmakoterapie. Praha: Farmakon Press, spol. s.r.o, 2023, vol. 19, No 3, p. 20-24. ISSN 1801-1209.
      URL
      Name (in English): The combination of obinutuzumab and venetoclax in the treatment of chronic lymphocytic leukemia
      RIV/00216224:14110/23:00133222 Article in a journal. Czech. Czech Republic.
      Arpáš, Tomáš (703 Slovakia, belonging to the institution) -- Prchlíková, Adéla (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; venetoclax; obinutuzumab; first-line treatment
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/1/2024 13:40.
      More: https://is.muni.cz/publication/2365602/en
    12. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM.
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, A. FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. In 23. Pražské hematologické dny, Praha. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 1/2/2023 10:22.
      More: https://is.muni.cz/publication/2251883/en
    13. Leukemie z vlasatých buněk (Hairy Cell Leukemia)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Leukemie z vlasatých buněk (Hairy Cell Leukemia). In Tomáš Büchler. Klinická onkologie. 1st ed. Praha: Maxdorf, 2023, p. 362-364. Jessenius. ISBN 978-80-7345-758-7.
      URL
      Name (in English): Hairy Cell Leukemia
      RIV/00216224:14110/23:00131661 Chapter(s) of a specialized book. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: hairy cell leukemia
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/3/2024 12:58.
      More: https://is.muni.cz/publication/2309919/en
    14. Prevence a léčba kardiovaskulárních a krvácivých komplikací u nemocných s chronickou lymfocytární leukemií léčených inhibitory Brutonovy kinázy (Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding)
      PANOVSKÁ, Anna, Tomáš ARPÁŠ, M. ŠIMKOVIČ, M. ŠPAČEK, T. PAPAJÍK, D. LYSÁK, Lucie BEZDĚKOVÁ and Michael DOUBEK. Prevence a léčba kardiovaskulárních a krvácivých komplikací u nemocných s chronickou lymfocytární leukemií léčených inhibitory Brutonovy kinázy (Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding). Transfuze a hematologie dnes. Praha: Česká lékařská společnost J. E. Purkyně, 2023, vol. 29, No 3, p. 177-184. ISSN 1213-5763. Available from: https://dx.doi.org/10.48095/cctahd2023prolekare.cz12.
      URL
      Name (in English): Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding
      RIV/00216224:14110/23:00133220 Article in a journal. Czech. Czech Republic.
      Panovská, Anna (203 Czech Republic, belonging to the institution) -- Arpáš, Tomáš (703 Slovakia, belonging to the institution) -- Šimkovič, M. (203 Czech Republic) -- Špaček, M. (203 Czech Republic) -- Papajík, T. (203 Czech Republic) -- Lysák, D. (203 Czech Republic) -- Bezděková, Lucie (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: bleeding; ibrutinib; arterial hypertension; chronic lymphocytic leukaemia; acalabrutinib; BTK inhibitor; atrial fibrillation
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/3/2024 12:21.
      More: https://is.muni.cz/publication/2365580/en
    15. Prolymfocytární leukemie (Prolymphocytic leukemia)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Prolymfocytární leukemie (Prolymphocytic leukemia). In Tomáš Büchler. Klinická onkologie. 1st ed. Praha: Maxdorf, 2023, p. 360-362. Jessenius. ISBN 978-80-7345-758-7.
      URL
      Name (in English): Prolymphocytic leukemia
      RIV/00216224:14110/23:00131660 Chapter(s) of a specialized book. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: prolymphocytic leukemia
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/3/2024 14:04.
      More: https://is.muni.cz/publication/2309918/en
    16. The interplay between BcR signaling and the p53 pathway upon DNA damage in primary CLL cells.
      PEŠOVÁ, Michaela, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Veronika MANČÍKOVÁ, Robert HELMA, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Tomáš ARPÁŠ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. The interplay between BcR signaling and the p53 pathway upon DNA damage in primary CLL cells. In XX. International Workshop on CLL (iwCLL 2023), Boston, USA, říjen 2023. 2023.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 8/1/2024 08:25.
      More: https://is.muni.cz/publication/2357968/en
    17. Transcription factor FoxO1 Mediates Adaptive Increase in Akt Activity and Cell Survival During BCR Inhibitor Therapy in CLL.
      MRÁZ, Marek, Laura ONDRIŠOVÁ, Václav ŠEDA, Eva HOFERKOVÁ, G. CHIODIN, Kryštof HLAVÁČ, Lenka KOŠŤÁLOVÁ, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel FILIP, Pedro ZENI, Jan OPPELT, Anna PANOVSKÁ, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, M. ŠIMKOVIČ, F. VRBACKÝ, Daniel LYSÁK, SM. FERNANDES, A. DAVIDS, A. MAIQUES-DIAZ, S. CHARALAMPOPOULOU, J. MARTIN-SUBERO, J. BROWN, Michael DOUBEK, F. FORCONI and Jiří MAYER. Transcription factor FoxO1 Mediates Adaptive Increase in Akt Activity and Cell Survival During BCR Inhibitor Therapy in CLL. In XX. International Workshop on CLL (iwCLL 2023), Boston, USA. 2023.
      URL
      RIV/00216224:14740/23:00132790 Conference abstract. English. United States of America.
      Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution) -- Ondrišová, Laura (703 Slovakia, belonging to the institution) -- Šeda, Václav (203 Czech Republic, belonging to the institution) -- Hoferková, Eva (203 Czech Republic, belonging to the institution) -- Hlaváč, Kryštof (203 Czech Republic, belonging to the institution) -- Košťálová, Lenka (203 Czech Republic, belonging to the institution) -- Mladonická Pavlasová, Gabriela (203 Czech Republic, belonging to the institution) -- Filip, Daniel (703 Slovakia, belonging to the institution) -- Zeni, Pedro (76 Brazil, belonging to the institution) -- Oppelt, Jan (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Lysák, Daniel (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; BCR inhibitor therapy; FoxO1
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 25/3/2024 11:04.
      More: https://is.muni.cz/publication/2356397/en

    2022

    1. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
      ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, Patrik ČECH, Petra ŠMUHAŘOVÁ, Miroslav BOUDNÝ, Martina ORŠULOVÁ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK, Karla PLEVOVÁ and Marie JAROŠOVÁ. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2022, vol. 12, June 2022, p. 1-11. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2022.859618.
      URL
      RIV/00216224:14110/22:00126419 Article in a journal. English. Switzerland.
      Ondroušková, Eva (203 Czech Republic, belonging to the institution) -- Bohúnová, Michaela (703 Slovakia, belonging to the institution) -- Závacká, Kristýna (203 Czech Republic, belonging to the institution) -- Čech, Patrik (203 Czech Republic, belonging to the institution) -- Šmuhařová, Petra (203 Czech Republic, belonging to the institution) -- Boudný, Miroslav (203 Czech Republic, belonging to the institution) -- Oršulová, Martina (703 Slovakia, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Jarošová, Marie (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; MYC; complex karyotype; 8q24 gain; prognosis
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/8/2022 13:02.
      More: https://is.muni.cz/publication/2211030/en
    2. Dynamics of genomic aberrations in relation to disease activity in untreated patients with chronic lymphocytic leukemia
      NAVRKALOVÁ, Veronika, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Tomáš REIGL, Martina VALIŠOVÁ, Michaela BOHÚNOVÁ, Marcela ŽENATOVÁ, Lenka RADOVÁ, Anna PANOVSKÁ and Šárka POSPÍŠILOVÁ. Dynamics of genomic aberrations in relation to disease activity in untreated patients with chronic lymphocytic leukemia. In EHA 2022 in HemaSphere 2022; 6(S3): 998-999. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 17/8/2022 10:14.
      More: https://is.muni.cz/publication/2211825/en
    3. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
      OLBERTOVÁ, Helena, Karla PLEVOVÁ, Šárka PAVLOVÁ, Jitka MALCIKOVA, Jana KOTAŠKOVÁ, Kamila STRÁNSKÁ, Michaela ŠPUNAROVÁ, Martin TRBUŠEK, Veronika NAVRKALOVÁ, Barbara DVOŘÁČKOVÁ, Nikola TOM, Karol PÁL, Marie JAROŠOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. London: BMC, 2022, vol. 22, No 1, p. 1-11. ISSN 1471-2407. Available from: https://dx.doi.org/10.1186/s12885-022-09221-z.
      URL
      RIV/00216224:14110/22:00127828 Article in a journal. English. United Kingdom of Great Britain and Northern Ireland.
      Olbertová, Helena (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Stránská, Kamila (203 Czech Republic, belonging to the institution) -- Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution) -- Navrkalová, Veronika (203 Czech Republic, belonging to the institution) -- Dvořáčková, Barbara (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Jarošová, Marie (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Chronic Lymphocytic Leukemia; Telomere; TP53; Clonal evolution; BCR signaling
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 6/11/2023 07:53.
      More: https://is.muni.cz/publication/2245079/en
    4. Exploring clonal evolution in CLL: Analysis by whole exome sequencing.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Marcela ŽENATOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jana KOTAŠKOVÁ, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Exploring clonal evolution in CLL: Analysis by whole exome sequencing. In 2nd Translational Research Conference Chronic Lymphocytic Leukaemia, E-conference. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 21/11/2022 15:19.
      More: https://is.muni.cz/publication/2233316/en
    5. Exploring different aspects of clonal evolution in chronic lymphocytic leukemia
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Kamila STRÁNSKÁ, Marcela ŽENATOVÁ, Martina VALIŠOVÁ, Kamila RÉBLOVÁ, Terézia KURUCOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jana KOTAŠKOVÁ and Karla PLEVOVÁ. Exploring different aspects of clonal evolution in chronic lymphocytic leukemia. In Mendel Genetics Conference 2022. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/8/2022 13:55.
      More: https://is.muni.cz/publication/2211936/en
    6. Exploring different aspects of clonal evolution in chronic lymphocytic leukemia.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Jakub Paweł PORC, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Kamila STRÁNSKÁ, Marcela ŽENATOVÁ, Martina VALIŠOVÁ, Kamila RÉBLOVÁ, Terézia KURUCOVÁ, Karolína ČERNOVSKÁ, Anna PANOVSKÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jana KOTAŠKOVÁ and Karla PLEVOVÁ. Exploring different aspects of clonal evolution in chronic lymphocytic leukemia. In EMBO Workshop, Itálie, Rimini. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 9/12/2022 15:32.
      More: https://is.muni.cz/publication/2238284/en
    7. GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
      ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Tomáš LOJA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, S. ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies. In XXXIV. Olomoucké hematologické dny in Transfuze a hematologie dnes. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 15/12/2022 10:04.
      More: https://is.muni.cz/publication/2239823/en
    8. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib.
      ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, Anna PANOVSKÁ, Michael DOUBEK, M. DAVIDS, J. BROWN, Jiří MAYER and Marek MRÁZ. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib. In 22. Pražské hematologické dny Hematologie, Praha. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 21/11/2022 13:24.
      More: https://is.muni.cz/publication/2233287/en
    9. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. (Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene)
      BRYJOVÁ, Lenka, Eva ONDROUŠKOVÁ, Kateřina ČÁBELOVÁ, Jiří ŠMEJKAL, Petra ŠMUHAŘOVÁ, Jana KOTAŠKOVÁ, Andrea MAREČKOVÁ, Michaela BOHÚNOVÁ, Ivana JEŽÍŠKOVÁ, Adam FOLTA, Dagmar SMITALOVÁ, Michael DOUBEK, Barbora WEINBERGEROVÁ, Libor ČERVINEK, Anna PANOVSKÁ, Daniela ŽÁČKOVÁ and Marie JAROŠOVÁ. Komplexní cytogenomická a molekulárně biologická analýza nádorového genomu pacientů s myeloidními malignitami se zaměřením na cílenou analýzu genu MECOM. (Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene). In Celostátní sjezd Společnosti lékařské genetiky a genomiky ČLS JEP a 55. výroční cytogenetická konference, Praha. 2022.
      Name (in English): Comprehensive cytogenomic and molecular biological analysis of the tumor genome of patients with myeloid malignancies with a focus on targeted analysis of the MECOM gene
      RIV/00216224:14110/22:00129710 Conference abstract. Czech. Czech Republic.
      Bryjová, Lenka (203 Czech Republic, belonging to the institution) -- Ondroušková, Eva (203 Czech Republic, belonging to the institution) -- Čábelová, Kateřina (203 Czech Republic, belonging to the institution) -- Šmejkal, Jiří (203 Czech Republic, belonging to the institution) -- Šmuhařová, Petra (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Marečková, Andrea (203 Czech Republic, belonging to the institution) -- Bohúnová, Michaela (703 Slovakia, belonging to the institution) -- Ježíšková, Ivana (203 Czech Republic, belonging to the institution) -- Folta, Adam (203 Czech Republic) -- Smitalová, Dagmar (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Weinbergerová, Barbora (203 Czech Republic, belonging to the institution) -- Červinek, Libor (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Žáčková, Daniela (203 Czech Republic, belonging to the institution) -- Jarošová, Marie (203 Czech Republic, belonging to the institution)
      Keywords in English: cytogenomic analysis; molecular biological analysis; tumour genome; myeloid malignancies; MECOM
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/5/2023 13:39.
      More: https://is.muni.cz/publication/2233850/en
    10. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene
      POPPOVÁ, Lucie, Šárka PAVLOVÁ, Beatriz GONZALEZ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Gabrijela DUMBOVIC, Pavlína JANOVSKÁ, Vojtěch BYSTRÝ, Anna PANOVSKÁ, Lucie BEZDĚKOVÁ, Stanislava MAŠLEJOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Marcela KRZYŽÁNKOVÁ, Marek BORSKÝ, Jiří MAYER, Vítězslav BRYJA, Sergio ALONSO and Šárka POSPÍŠILOVÁ. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene. Epigenetics. Philadelphia: TAYLOR & FRANCIS INC, 2022, vol. 17, No 12, p. 1628-1635. ISSN 1559-2294. Available from: https://dx.doi.org/10.1080/15592294.2022.2050004.
      URL
      RIV/00216224:14110/22:00127827 Article in a journal. English. United States of America.
      Poppová, Lucie (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Janovská, Pavlína (203 Czech Republic, belonging to the institution) -- Bystrý, Vojtěch (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Bezděková, Lucie (203 Czech Republic, belonging to the institution) -- Mašlejová, Stanislava (703 Slovakia, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Krzyžánková, Marcela (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Bryja, Vítězslav (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: WNT5A; chronic lymphocytic leukaemia; methylation; i-CLL; m-CLL
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Eva Dubská, učo 77638. Changed: 5/4/2024 21:08.
      More: https://is.muni.cz/publication/2245078/en
    11. Moderní léčba chronické lymfocytární leukemie – příklad personalizované hematologické léčby.
      DOUBEK, Michael, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Tomáš ARPÁŠ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Michaela PEŠOVÁ, Jitka MALČÍKOVÁ and Šárka POSPÍŠILOVÁ. Moderní léčba chronické lymfocytární leukemie – příklad personalizované hematologické léčby. In XXV. Biologické dny, Brno. 2022.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 24/11/2022 09:02.
      More: https://is.muni.cz/publication/2233853/en

    2021

    1. CLLEAR – Czech national registry of CLL patients: complete data analysis 2021.
      DOUBEK, Michael, Lucie NEKVINDOVÁ, M. ŠIMKOVIČ, R. URBANOVÁ, Martina ORŠULOVÁ, Daniel LYSÁK, Martin BREJCHA, Jana ZUCHNICKÁ, Anna PANOVSKÁ, P. VODÁREK, P. OBRTLÍKOVÁ, L. MAHAMMAD, Yvona BRYCHTOVÁ, P. RYZNEROVÁ, D. ECSIOVÁ, Stanislava MAŠLEJOVÁ, Lucie BEZDĚKOVÁ, H. POUL, J. NOVÁK, Zuzana KUBOVÁ, M. GENSKÝ, Hana ŠKABRAHOVÁ, M. VEITOVÁ, K. KLÁSKOVÁ, Šárka POSPÍŠILOVÁ, J. MOLINSKÝ, Z. KŘÍSTKOVÁ, Marek TRNĚNÝ, Jiří MAYER, Tomáš PAPAJÍK, Martin ŠPAČEK and Lukáš SMOLEJ. CLLEAR – Czech national registry of CLL patients: complete data analysis 2021. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/2/2022 06:43.
      More: https://is.muni.cz/publication/1830657/en
    2. CLLEAR – Český registr pacientů s chronickou lymfocytární leukemií: analýza dat 2021.
      DOUBEK, Michael, Lucie NEKVINDOVÁ, M. ŠIMKOVIČ, R. URBANOVÁ, Martina ORŠULOVÁ, Daniel LYSÁK, Martin BREJCHA, Jana ZUCHNICKÁ, Anna PANOVSKÁ, P. VODÁREK, P. OBRTLÍKOVÁ, L. MOHAMMAD, Yvona BRYCHTOVÁ, P. RYZNEROVÁ, ÉCSIOVÁ, Stanislava MAŠLEJOVÁ, Lucie BEZDĚKOVÁ, Hubert POUL, J. NOVÁK, Z. KUBOVÁ, M. GENSKÝ, Hana ŠKABRAHOVÁ, M. VEITOVÁ, K. KLÁSKOVÁ, Šárka POSPÍŠILOVÁ, J. MOLINSKÝ, Z. KŘÍSTKOVÁ, Marek TRNĚNÝ, Jiří MAYER, Tomáš PAPAJÍK, M. ŠPAČEK and Lukáš SMOLEJ. CLLEAR – Český registr pacientů s chronickou lymfocytární leukemií: analýza dat 2021. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 09:20.
      More: https://is.muni.cz/publication/1812459/en
    3. Detailed analysis of treatment-related clonal evolution in CLL through the identification of abnormal molecular pathways.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Detailed analysis of treatment-related clonal evolution in CLL through the identification of abnormal molecular pathways. In XIX International Conference on Chronic Lymphocytic Leukemia (iwCLL). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 31/1/2022 14:43.
      More: https://is.muni.cz/publication/1829607/en
    4. Duplikace 8q24 v chronické lymfocytární leukémii: Cytogentická a molekulárně-biologická analýza aberací genu MYC.
      ONDROUŠKOVÁ, Eva, Michaela BOHÚNOVÁ, Kristýna ZÁVACKÁ, P. ČECH, Petra ŠMUHAŘOVÁ, Karla PLEVOVÁ, Miroslav BOUDNÝ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK and Marie JAROŠOVÁ. Duplikace 8q24 v chronické lymfocytární leukémii: Cytogentická a molekulárně-biologická analýza aberací genu MYC. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 10:33.
      More: https://is.muni.cz/publication/1811808/en
    5. Dynamika mutací a chromozomálních aberací v závislosti na aktivitě CLL u neléčených pacientů.
      NAVRKALOVÁ, Veronika, Jana KOTAŠKOVÁ, Martina VALIŠOVÁ, Marcela ŽENATOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Dynamika mutací a chromozomálních aberací v závislosti na aktivitě CLL u neléčených pacientů. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes. 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/2/2022 13:51.
      More: https://is.muni.cz/publication/1830780/en
    6. Dynamika mutací a chromozomálních aberací v závislosti na aktivitě CLL u neléčených pacientů.
      NAVRKALOVÁ, Veronika, Jana KOTAŠKOVÁ, Martina VALIŠOVÁ, Marcela ŽENATOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Dynamika mutací a chromozomálních aberací v závislosti na aktivitě CLL u neléčených pacientů. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 10:13.
      More: https://is.muni.cz/publication/1811802/en
    7. Exploring clonal evolution and genetic causes of therapy failure in chronic lymphocytic leukemia.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Anna PANOVSKÁ, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Exploring clonal evolution and genetic causes of therapy failure in chronic lymphocytic leukemia. In ESHG 2021. 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 07:57.
      More: https://is.muni.cz/publication/1812422/en
    8. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
      ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Gabriela MLADONICKÁ PAVLASOVÁ, Daniel ZICHA, Marie KUDLIČKOVÁ PEŠKOVÁ, Jan KŘIVÁNEK, Květoslava MATULOVÁ, Leoš KŘEN, V. BENES, Markéta LITZMANOVÁ, Marek BORSKÝ, Jan OPPELT, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Z. TAN, S.X. ZHANG, Michael DOUBEK, Kateřina AMRUZ ČERNÁ, Jiří MAYER and Marek MRÁZ. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 138, No 9, p. 758-772. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020008101.
      URL
      RIV/00216224:14740/21:00123376 Article in a journal. English. United States of America.
      Šeda, Václav (203 Czech Republic, belonging to the institution) -- Vojáčková, Eva (203 Czech Republic, belonging to the institution) -- Ondrišová, Laura (703 Slovakia, belonging to the institution) -- Košťálová, Lenka (203 Czech Republic, belonging to the institution) -- Sharma, Sonali (356 India, belonging to the institution) -- Loja, Tomáš (703 Slovakia, belonging to the institution) -- Mladonická Pavlasová, Gabriela (203 Czech Republic, belonging to the institution) -- Zicha, Daniel (203 Czech Republic) -- Kudličková Pešková, Marie (203 Czech Republic, belonging to the institution) -- Křivánek, Jan (203 Czech Republic, belonging to the institution) -- Matulová, Květoslava (203 Czech Republic, belonging to the institution) -- Křen, Leoš (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Oppelt, Jan (203 Czech Republic, belonging to the institution) -- Verner, Jan (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Amruz Černá, Kateřina (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: DOCKING PROTEIN GAB1B-CELLSBONE-MARROWCHEMOKINE RECEPTORL-SELECTINP110-GAMMA ISOFORMEPIDERMAL-GROWTHTYROSINE KINASEPI3 KINASEIBRUTINIB
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 18/5/2022 13:27.
      More: https://is.muni.cz/publication/1813384/en
    9. FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target.
      ŠEDA, Václav, E. VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Zhuowen TAN, Shelley ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target. In 26th Congress of the European Hematology Association, červen 2021 in HemaSphere. 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/2/2022 06:51.
      More: https://is.muni.cz/publication/1830658/en
    10. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
      ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/2/2022 07:03.
      More: https://is.muni.cz/publication/1830661/en
    11. GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
      MRÁZ, Marek, Václav ŠEDA, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Jiří MAYER. GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target. In XXVI. CSBMB 2021. 2021.
      Name (in English): GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target

      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 09:43.
      More: https://is.muni.cz/publication/1811797/en
    12. GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory.
      ŠEDA, Václav, Eva VOJÁČKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, D. ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Zhuowen TAN, Shelley ZHANG, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 09:28.
      More: https://is.muni.cz/publication/1812461/en
    13. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib
      ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Kateřina AMRUZ ČERNÁ, Sonali SHARMA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, S.M. FERNANDES, Anna PANOVSKÁ, Michael DOUBEK, M.S. DAVIDS, J.R. BROWN, Jiří MAYER and Marek MRÁZ. IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2021, vol. 106, No 11, p. 2995-2999. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2021.278644.
      URL
      RIV/00216224:14740/21:00123375 Article in a journal. English. Italy.
      Šandová, Veronika (203 Czech Republic, belonging to the institution) -- Mladonická Pavlasová, Gabriela (203 Czech Republic, belonging to the institution) -- Šeda, Václav (203 Czech Republic, belonging to the institution) -- Amruz Černá, Kateřina (203 Czech Republic, belonging to the institution) -- Sharma, Sonali (356 India, belonging to the institution) -- Palušová, Veronika (703 Slovakia, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: COMPLEMENTEXPRESSIONRITUXIMABANTIGENCELLS
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 22/12/2021 16:07.
      More: https://is.muni.cz/publication/1813380/en
    14. Klinický dopad a evoluce minoritních TP53-mutovaných klonů v kontextu různých terapeutických režimů u CLL.
      MALČÍKOVÁ, Jitka, Šárka PAVLOVÁ, Barbara KUNT VONKOVÁ, Lenka RADOVÁ, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Karol PÁL, Barbara DVOŘÁČKOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, Eva ONDROUŠKOVÁ, Anna PANOVSKÁ, Stanislava MAŠLEJOVÁ, Lucie BEZDĚKOVÁ, J. ZUCHNICKÁ, R. URBANOVÁ, Daniel LYSÁK, J. NOVÁK, Martin BREJCHA and Michael DOUBEK. Klinický dopad a evoluce minoritních TP53-mutovaných klonů v kontextu různých terapeutických režimů u CLL. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 09:07.
      More: https://is.muni.cz/publication/1812457/en
    15. Klonální evoluce CLL – význam BCR receptoru a abnormalit genu TP53.
      POSPÍŠILOVÁ, Šárka, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Karla PLEVOVÁ, Kamila STRÁNSKÁ, Barbara KUNT VONKOVÁ, Jana KOTAŠKOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Stanislava MAŠLEJOVÁ, L. NĚMCOVÁ, Michael DOUBEK and Jiří MAYER. Klonální evoluce CLL – význam BCR receptoru a abnormalit genu TP53. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 12:11.
      More: https://is.muni.cz/publication/1811837/en
    16. Klonální evoluce CLL podmíněná léčbou: analýza pomocí celoexomového sekvenování.
      ZÁVACKÁ, Kristýna, Petr TAUŠ, Karol PÁL, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Milan KABÁT, Anna PANOVSKÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ. Klonální evoluce CLL podmíněná léčbou: analýza pomocí celoexomového sekvenování. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/12/2021 09:32.
      More: https://is.muni.cz/publication/1812462/en
    17. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
      MALČÍKOVÁ, Jitka, Šárka PAVLOVÁ, Barbara KUNT VONKOVÁ, Lenka RADOVÁ, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Karol PÁL, Barbara DVOŘÁČKOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, Eva ONDROUŠKOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Kristýna ZÁVACKÁ, Boris TICHÝ, Nikola TOM, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. Washington DC, USA: American Society of Hematology, 2021, vol. 138, No 25, p. 2670-2685. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.2020009530.
      URL
      RIV/00216224:14740/21:00119667 Article in a journal. English. United States of America.
      Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Kunt Vonková, Barbara (203 Czech Republic, belonging to the institution) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Dvořáčková, Barbara (203 Czech Republic, belonging to the institution) -- Ženatová, Marcela (203 Czech Republic, belonging to the institution) -- Hynšt, Jakub (203 Czech Republic, belonging to the institution) -- Ondroušková, Eva (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Závacká, Kristýna (203 Czech Republic, belonging to the institution) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: Low-burden TP53 mutations; CLL; clinical impact; clonal evolution
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 25/2/2022 22:08.
      More: https://is.muni.cz/publication/1836757/en
    18. LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
      NAVRKALOVÁ, Veronika, Karla PLEVOVÁ, Jakub HYNŠT, Karol PÁL, Andrea MAREČKOVÁ, Tomáš REIGL, Hana JELÍNKOVÁ, Zuzana VRZALOVÁ, Kamila STRÁNSKÁ, Šárka PAVLOVÁ, Anna PANOVSKÁ, Andrea JANÍKOVÁ, Michael DOUBEK, Jana KOTAŠKOVÁ and Šárka POSPÍŠILOVÁ. LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies. The journal of molecular diagnostics. Bethesda, MD: American Society for Investigative Pathology/Association for Molecular Pathology, 2021, vol. 23, No 8, p. 959-974. ISSN 1525-1578. Available from: https://dx.doi.org/10.1016/j.jmoldx.2021.05.007.
      URL
      RIV/00216224:14740/21:00124277 Article in a journal. English. United States of America.
      Navrkalová, Veronika (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Hynšt, Jakub (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Marečková, Andrea (203 Czech Republic, belonging to the institution) -- Reigl, Tomáš (203 Czech Republic, belonging to the institution) -- Jelínková, Hana (203 Czech Republic) -- Vrzalová, Zuzana (203 Czech Republic, belonging to the institution) -- Stránská, Kamila (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Janíková, Andrea (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: LYNX; Lymphoid Malignancies; Prognostic and Predictive Markers
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 24/2/2022 15:56.
      More: https://is.muni.cz/publication/1836805/en
    19. PI3KD inhibitor idelalisib snižuje hladiny CD20 u chronické lymfocytární leukémie inhibicí IL4-STAT6 signální dráhy.
      ŠANDOVÁ, Veronika, Gabriela MLADONICKÁ PAVLASOVÁ, Václav ŠEDA, Sonali SHARMA, Veronika PALUŠOVÁ, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ, SM. FERNANDES, Anna PANOVSKÁ, Michael DOUBEK, MS. DAVIDS, JR. BROWN, Jiří MAYER and Marek MRÁZ. PI3KD inhibitor idelalisib snižuje hladiny CD20 u chronické lymfocytární leukémie inhibicí IL4-STAT6 signální dráhy. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 10:09.
      More: https://is.muni.cz/publication/1811800/en
    20. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion
      BORSKÝ, Marek, Viera HRABČÁKOVÁ, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Petr MULLER, Jiří MAYER, Martin TRBUŠEK and Marek MRÁZ. Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2021, vol. 111, December 2021, p. 1-11. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2021.106684.
      URL
      RIV/00216224:14110/21:00124279 Article in a journal. English. United Kingdom of Great Britain and Northern Ireland.
      Borský, Marek (203 Czech Republic, belonging to the institution) -- Hrabčáková, Viera (703 Slovakia, belonging to the institution) -- Novotná, Jitka (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Muller, Petr (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, guarantor, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution)
      Keywords in English: Chronic lymphocytic leukemia/CLL; Rituximab; Complement; Recrudescence; Peripheral blood repopulation
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 4/3/2022 09:52.
      More: https://is.muni.cz/publication/1836826/en
    21. Využití funkční analýzy jako doplňkového nástroje při analýze genu TP53 u pacientů s chronickou lymfocytární leukémií.
      GOMBÍKOVÁ, Johana, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Barbara DVOŘÁČKOVÁ, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Michaela PEŠOVÁ, Marcela ŽENATOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Využití funkční analýzy jako doplňkového nástroje při analýze genu TP53 u pacientů s chronickou lymfocytární leukémií. In II. Český hematologický a transfuziologický sjezd v Transfuze a Hematologie Dnes (2021). 2021.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 18/12/2021 12:24.
      More: https://is.muni.cz/publication/1811841/en

    2020

    1. Dynamika vývoje mutací TP53 u pacientů s chronickou lymfocytární leukemií během léčby BCR inhibitory.
      KUNT VONKOVÁ, Barbara, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Barbara DVOŘÁČKOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, S. MAŠLEJOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Boris TICHÝ, Karol PÁL, Jiří MAYER and Šárka POSPÍŠILOVÁ. Dynamika vývoje mutací TP53 u pacientů s chronickou lymfocytární leukemií během léčby BCR inhibitory. In 20. Pražské hematologické dny (Hematologie 2020), Praha. 2020.
      Changed by: Lucie Němcová, učo 113323. Changed: 10/10/2022 10:29.
      More: https://is.muni.cz/publication/1689896/en
    2. Chronická lymfocytární leukemie
      PANOVSKÁ, Anna, Yvona BRYCHTOVÁ and Michael DOUBEK. Chronická lymfocytární leukemie. In Speciální onkologie. 2. vydání. Praha: Maxdorf, 2020, p. 180-185. ISBN 978-80-7345-651-1.
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 1/4/2021 12:35.
      More: https://is.muni.cz/publication/1706556/en
    3. Leukemie z vlasatých buněk
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Leukemie z vlasatých buněk. In Speciální onkologie. 2. vydání. Praxa: Maxdorf, 2020, p. 197-201. ISBN 978-80-7345-651-1.
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 8/4/2021 10:02.
      More: https://is.muni.cz/publication/1706558/en
    4. Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact.
      MALČÍKOVÁ, Jitka, Šárka PAVLOVÁ, Barbara VONKOVÁ, Jana KOTAŠKOVÁ, Lenka RADOVÁ, Karla PLEVOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, Barbara DVOŘÁČKOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Boris TICHÝ, Nikola TOM, Karol PÁL, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact. In XVIII. International Workshop on CLL (iwCLL), Edinburgh, Spojené království. 2020. ISSN 1042-8194.
      URL
      RIV/00216224:14740/20:00114040 Conference abstract. English. United Kingdom of Great Britain and Northern Ireland.
      Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Vonková, Barbara (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Ženatová, Marcela (203 Czech Republic) -- Hynšt, Jakub (203 Czech Republic, belonging to the institution) -- Dvořáčková, Barbara (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Mayer, Jiří (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: Minor-clone TP53; CLL patients
      International impact: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 16/3/2021 19:24.
      More: https://is.muni.cz/publication/1613376/en
    5. Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia
      STRÁNSKÁ, Kamila, Karla PLEVOVÁ, Hana SKUHROVÁ FRANCOVÁ, Hana ŠKABRAHOVÁ, Magdalena VON JAGWITZ-BIEGNITZ, Lenka RADOVÁ, Anna PANOVSKÁ, Stanislava HROBKOVÁ, Yvona BRYCHTOVÁ, Renata URBANOVÁ, Lukáš SMOLEJ, Martin SIMKOVIC, Jana ZUCHNICKÁ, Lekaa MOHAMMADOVA, Martin ŠPAČEK, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia. Biomedical Papers : Univerzita Palackého v Olomouci. Olomouc: PALACKY UNIV, MEDICAL FAC, CENTRAL LIBRARY, 2020, vol. 164, No 4, p. 425-434. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2019.046.
      URL
      Name (in English): Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia
      RIV/00216224:14740/20:00118628 Article in a journal. English. Czech Republic.
      Stránská, Kamila (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Škabrahová, Hana (203 Czech Republic, belonging to the institution) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Hrobková, Stanislava (703 Slovakia, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Urbanová, Renata (203 Czech Republic) -- Smolej, Lukáš (203 Czech Republic) -- Simkovic, Martin (203 Czech Republic) -- Zuchnická, Jana (203 Czech Republic) -- Špaček, Martin (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CLL; B-cell receptor; clonality; questionnaire; patient history; biological risk factor
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 17/3/2021 11:57.
      More: https://is.muni.cz/publication/1692085/en
    6. Prolymfocytární leukemie
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Prolymfocytární leukemie. In Speciální onkologie. 2. vydání. Praha: Maxdorf, 2020, p. 191-197. ISBN 978-80-7345-651-1.
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 8/4/2021 10:09.
      More: https://is.muni.cz/publication/1706557/en
    7. Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group
      PANOVSKÁ, Anna, Lucie BEZDĚKOVÁ, Lucie NEKVINDOVÁ, Martin SPACEK, Martin SIMKOVIC, Tomas PAPAJIK, Martin BREJCHA, Daniel LYSAK, Jana ZUCHNICKA, Jan NOVAK, David STAROSTKA, Hynek POUL, Filip VRBACKY, Pavel VODAREK, Renata URBANOVA, Karla PLEVOVÁ, Šárka POSPÍŠILOVÁ, Stanislava MASLEJOVA, Yvona BRYCHTOVÁ, Eva KORIŤÁKOVÁ, Lukas SMOLEJ and Michael DOUBEK. Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2020, vol. 38, No 4, p. 509-516. ISSN 0278-0232. Available from: https://dx.doi.org/10.1002/hon.2744.
      URL
      RIV/00216224:14740/20:00116170 Article in a journal. English. United States of America.
      Panovská, Anna (203 Czech Republic, belonging to the institution) -- Bezděková, Lucie (203 Czech Republic, belonging to the institution) -- Nekvindová, Lucie (203 Czech Republic) -- Spacek, Martin (203 Czech Republic) -- Simkovic, Martin (203 Czech Republic) -- Papajik, Tomas (203 Czech Republic) -- Brejcha, Martin (203 Czech Republic) -- Lysak, Daniel (203 Czech Republic) -- Zuchnicka, Jana (203 Czech Republic) -- Novak, Jan (203 Czech Republic) -- Starostka, David (203 Czech Republic) -- Poul, Hynek (203 Czech Republic) -- Vrbacky, Filip (203 Czech Republic) -- Vodarek, Pavel (203 Czech Republic) -- Urbanova, Renata (203 Czech Republic) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Maslejova, Stanislava (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Koriťáková, Eva (203 Czech Republic) -- Smolej, Lukas (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CIRS; CLL; frontline treatment; obinutuzumab-chlorambucil; rituximab-bendamustine; rituximab-chlorambucil
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 9/11/2020 10:38.
      More: https://is.muni.cz/publication/1673757/en

    2019

    1. Biologická a klinická analýza souboru nemocných s refrakterní a relabující chronickou lymfocytární leukémií (Biological and clinical analysis of a group of patients with refractory and relapsing chronic lymphocytic leukemia)
      JAROŠOVÁ, Marie, Eva ONDROUŠKOVÁ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Barbora RICHTEROVÁ, Michaela BOHÚNOVÁ, Jiří ŠMEJKAL, P. ŠMUHAŘOVÁ, Lenka RADOVÁ, Šárka PAVLOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Lucie NĚMCOVÁ, S. MEŠLEJOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Biologická a klinická analýza souboru nemocných s refrakterní a relabující chronickou lymfocytární leukémií (Biological and clinical analysis of a group of patients with refractory and relapsing chronic lymphocytic leukemia). In Celostátní sjezd Společnosti lékařské genetika a genomiky ČLS JEP a 52. Výroční cytogenetická konference, Plzeň. 2019.
      Name (in English): Biological and clinical analysis of a group of patients with refractory and relapsing chronic lymphocytic leukemia
      RIV/00216224:14110/19:00108579 Conference abstract. Czech. Czech Republic.
      Jarošová, Marie (203 Czech Republic, guarantor, belonging to the institution) -- Ondroušková, Eva (203 Czech Republic) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Richterová, Barbora (203 Czech Republic) -- Bohúnová, Michaela (703 Slovakia, belonging to the institution) -- Šmejkal, Jiří (203 Czech Republic) -- Radová, Lenka (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic) -- Němcová, Lucie (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: refractory and relapsing chronic lymphocytic leukemia
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 20/4/2020 08:53.
      More: https://is.muni.cz/publication/1609589/en
    2. Complex structural variants and formation of de novo fusion genes in chronic lymphocytic leukemia.
      PLEVOVÁ, K, T. RAUSCH, Jakub HYNŠT, Marie JAROŠOVÁ, Kristýna ZÁVACKÁ, Eva ONDROUŠKOVÁ, Lenka RADOVÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Vladimír BENEŠ and Šárka POSPÍŠILOVÁ. Complex structural variants and formation of de novo fusion genes in chronic lymphocytic leukemia. In XXXIII. Olomoucké hematologické dny, Olomouc. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 28/1/2020 13:52.
      More: https://is.muni.cz/publication/1612565/en
    3. Complex structural variants lead to gene inactivation rather than expression of de novo fusion genes in chronic lymphocytic leukemia
      PLEVOVÁ, Karla, Jakub HYNŠT, Kristýna ZÁVACKÁ, Marie JAROŠOVÁ, T. RAUSCH, Eva ONDROUŠKOVÁ, Lenka RADOVÁ, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Vladimír BENEŠ and Šárka POSPÍŠILOVÁ. Complex structural variants lead to gene inactivation rather than expression of de novo fusion genes in chronic lymphocytic leukemia. In 24th Congress of European Hematology Association, Amsterdam, Nizozemsko, in HemaSpehere. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 24/1/2020 07:00.
      More: https://is.muni.cz/publication/1609422/en
    4. Cytogenetika u CLL a role komplexního karyotypu.
      JAROŠOVÁ, Marie, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Eva ONDROUŠKOVÁ, Jiří ŠMEJKAL, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, L. NĚMCOVÁ, Lenka RADOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Cytogenetika u CLL a role komplexního karyotypu. In XIV. Brněnské hematologické dny, Brno. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 29/1/2020 12:26.
      More: https://is.muni.cz/publication/1613676/en
    5. Development of 3D drug-testing platform for chronic lymphocytic leukemia.
      SVOZILOVÁ, Hana, Lucy VOJTOVÁ, D. HORÁK, Jiří BALOUN, Radana STUDENÁ, Z. PLICHTA, V. PROKS, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Šárka POSPÍŠILOVÁ. Development of 3D drug-testing platform for chronic lymphocytic leukemia. In 24th European Hematology Association Cogress, Amsterdam, Nizozemsko in HemaSpehere. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 24/1/2020 06:18.
      More: https://is.muni.cz/publication/1609417/en
    6. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience (Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience)
      ŠPUNAROVÁ, Michaela, Nikola TOM, Šárka PAVLOVÁ, Marek MRÁZ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Anna BRZOBOHATÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience (Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience). Leukemia Research. Oxford: PERGAMON-ELSEVIER SCIENCE LTD, 2019, vol. 81, JUN 2019, p. 75-81. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.04.015.
      URL
      Name (in English): Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: clinical practice experience
      RIV/00216224:14110/19:00108468 Article in a journal. English. United Kingdom of Great Britain and Northern Ireland.
      Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Brzobohatá, Anna (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CLL; chemoimmunotherapy; deletion 11q22; IGHV; BIRC3; ATM
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/5/2020 13:41.
      More: https://is.muni.cz/publication/1531396/en
    7. Novel methodology for seeding leukemic B cells into porous scaffolds and for their DNA isolation
      SVOZILOVÁ, Hana, Lucy VOJTOVÁ, D. HORÁK, Jiří BALOUN, Radana STUDENÁ, Z. PLICHTA, V. PROKS, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Šárka POSPÍŠILOVÁ. Novel methodology for seeding leukemic B cells into porous scaffolds and for their DNA isolation. In Joint retreat 2019, Kouty u Ledče nad Sázavou. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 24/1/2020 13:24.
      More: https://is.muni.cz/publication/1609610/en
    8. Peripheral blood of CLL patients is repopulated with complement resistant malignant cells one day after rituximab infusion: possible implications for subsequent chemotherapy.
      BORSKÝ, Marek, Viera HRABČÁKOVÁ, J. NOVOTNÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER, Marek MRÁZ and Martin TRBUŠEK. Peripheral blood of CLL patients is repopulated with complement resistant malignant cells one day after rituximab infusion: possible implications for subsequent chemotherapy. In 10th International Conference Analytical Cytometry, Hotel Jizerka, Seč-Ústupky. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 12/2/2020 09:14.
      More: https://is.muni.cz/publication/1620356/en
    9. Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab
      ŠPAČEK, Martin, Petra OBRTLÍKOVÁ, Stanislava HROBKOVÁ, Eduard CMUNT, Josef KARBAN, Jan MOLINSKÝ, Martin ŠIMKOVIČ, Heidi MOCIKOVÁ, Lekaa MOHAMMADOVÁ, Anna PANOVSKÁ, Jan NOVÁK, Marek TRNĚNÝ, Lukáš SMOLEJ and Michael DOUBEK. Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab. Leukemia Research. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2019, vol. 79, APR 2019, p. 17-21. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2019.02.002.
      URL
      RIV/00216224:14110/19:00108491 Article in a journal. English. United Kingdom of Great Britain and Northern Ireland.
      Špaček, Martin (203 Czech Republic, guarantor) -- Obrtlíková, Petra (203 Czech Republic) -- Hrobková, Stanislava (703 Slovakia, belonging to the institution) -- Cmunt, Eduard (203 Czech Republic) -- Karban, Josef (203 Czech Republic) -- Molinský, Jan (203 Czech Republic) -- Šimkovič, Martin (203 Czech Republic) -- Mociková, Heidi (203 Czech Republic) -- Mohammadová, Lekaa (203 Czech Republic) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Novák, Jan (203 Czech Republic) -- Trněný, Marek (203 Czech Republic) -- Smolej, Lukáš (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: CLL; Bendamustine; Rituximab; Comorbid patients; CIRS; First-line treatment
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 22:16.
      More: https://is.muni.cz/publication/1545812/en
    10. Single-agent ibrutinib in RESONATE-2 (TM) and RESONATE (TM) versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
      SALLES, Gilles, Emmanuel BACHY, Lukáš SMOLEJ, Martin SIMKOVIC, Lucile BASEGGIO, Anna PANOVSKÁ, Herve BESSON, Nollaig HEALY, Jamie GARSIDE, Wafae IRAQI, Joris DIELS, Corinna PICK-LAUER, Martin SPACEK, Renata URBANOVA, Daniel LYSAK, Ruben HERMANS, Jessica LUNDBOM, Evelyne CALLET-BAUCHU and Michael DOUBEK. Single-agent ibrutinib in RESONATE-2 (TM) and RESONATE (TM) versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia. Annals of hematology. New York: Springer Verlag, 2019, vol. 98, No 12, p. 2749-2760. ISSN 0939-5555. Available from: https://dx.doi.org/10.1007/s00277-019-03830-8.
      URL
      RIV/00216224:14110/19:00112598 Article in a journal. English. United States of America.
      Salles, Gilles (250 France, guarantor) -- Bachy, Emmanuel (250 France) -- Smolej, Lukáš (203 Czech Republic) -- Simkovic, Martin (203 Czech Republic) -- Baseggio, Lucile (250 France) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Besson, Herve (372 Ireland) -- Healy, Nollaig (826 United Kingdom of Great Britain and Northern Ireland) -- Garside, Jamie (826 United Kingdom of Great Britain and Northern Ireland) -- Iraqi, Wafae (250 France) -- Diels, Joris (56 Belgium) -- Pick-Lauer, Corinna (276 Germany) -- Spacek, Martin (203 Czech Republic) -- Urbanova, Renata (203 Czech Republic) -- Hermans, Ruben (826 United Kingdom of Great Britain and Northern Ireland) -- Lundbom, Jessica (826 United Kingdom of Great Britain and Northern Ireland) -- Callet-Bauchu, Evelyne (250 France) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: Ibrutinib; Chronic lymphocytic leukemia; Real-world evidence; Randomized controlled trial; Progression-free survival; Overall survival
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 22:16.
      More: https://is.muni.cz/publication/1606864/en
    11. Srovnání počtu a alelické četnosti mutací genu TP53 u pacientů před první terapií a pacientů s relabující/refrakterní chronickou lymfocytární leukemií.
      VONKOVÁ, Barbara, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Jana KOTAŠKOVÁ, Jakub HYNŠT, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER and Šárka POSPÍŠILOVÁ. Srovnání počtu a alelické četnosti mutací genu TP53 u pacientů před první terapií a pacientů s relabující/refrakterní chronickou lymfocytární leukemií. In 63. Studentská vědecká konference, Brno. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 28/1/2020 13:36.
      More: https://is.muni.cz/publication/1612558/en
    12. Srovnání počtu a alelické četnosti mutací genu TP53 u pacientů před první terapií a pacientů s relabující/refrakterní chronickou lymfocytární leukemií.
      VONKOVÁ, Barbara, Šárka PAVLOVÁ, Jitka MALČÍKOVÁ, Jana KOTAŠKOVÁ, Karla PLEVOVÁ, Marcela ŽENATOVÁ, Jakub HYNŠT, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Boris TICHÝ, Karol PÁL, Jiří MAYER and Šárka POSPÍŠILOVÁ. Srovnání počtu a alelické četnosti mutací genu TP53 u pacientů před první terapií a pacientů s relabující/refrakterní chronickou lymfocytární leukemií. In XXXIII. Olomoucké hematologické dny, Olomouc. 2019.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 28/1/2020 13:17.
      More: https://is.muni.cz/publication/1612516/en

    2018

    1. CLLEAR český registr pacientů s chronickou lymfocytární leukemií – kompletní analýza dat
      DOUBEK, Michael, Eva KORIŤÁKOVÁ, R. URBANOVÁ, M. ŠIMKOVIČ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, P. VODÁREK, Martin LYSÁK, Martin BREJCHA, Jana ZUCHNICKÁ, P. OBRTLÍKOVÁ, P. RÝZNEROVÁ, M. MOTYČKOVÁ, Hana ŠKABRAHOVÁ, Šárka POSPÍŠILOVÁ, J. MOLINSKÝ, Marek TRNĚNÝ, Tomáš PAPAJÍK, Jiří MAYER, Lukáš SMOLEJ and M. ŠPAČEK. CLLEAR český registr pacientů s chronickou lymfocytární leukemií – kompletní analýza dat. In I. Český hematologický a transfuziologický sjezd, Praha in Transfuze a hematologie dnes. 2018.
      Czech.
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 26/11/2018 16:18.
      More: https://is.muni.cz/publication/1465676/en
    2. Cytogenetické změny a jejich klinický význam u relabujících a refrakterních CLL nemocných
      JAROŠOVÁ, Marie, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Eva ONDROUŠKOVÁ, Jiří ŠMEJKAL, Barbora RICHTEROVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Cytogenetické změny a jejich klinický význam u relabujících a refrakterních CLL nemocných. In 51. výroční Cytogenetická konference, Ostrava. 2018.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 13/2/2019 09:44.
      More: https://is.muni.cz/publication/1496448/en
    3. Častý výskyt dicentrických chromosomů u CLL nemocných s komplexním karyotypem
      RICHTEROVÁ, Barbora, Marie JAROŠOVÁ, Karla PLEVOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Eva ONDROUŠKOVÁ, Petra ŠMUHAŘOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Lenka RADOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Častý výskyt dicentrických chromosomů u CLL nemocných s komplexním karyotypem. In 51. výroční Cytogenetická konference, Ostrava. 2018.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 13/2/2019 10:00.
      More: https://is.muni.cz/publication/1496453/en
    4. Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes
      OLBERTOVÁ, Helena, Karla PLEVOVÁ, Jitka MALČÍKOVÁ, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Michaela ŠPUNAROVÁ, Martin TRBUŠEK, Veronika NAVRKALOVÁ, Barbara KANTOROVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
      Name (in English): Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes
      RIV/00216224:14740/18:00104529 Conference abstract. English.
      Olbertová, Helena (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution) -- Navrkalová, Veronika (203 Czech Republic, belonging to the institution) -- Kantorová, Barbara (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CLL; evolution; telomere
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 26/3/2019 15:38.
      More: https://is.muni.cz/publication/1469377/en
    5. Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience
      ŠPUNAROVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Kristina ĎURECHOVÁ, A. BRZOBOHATÁ, Anna FREIBERGEROVÁ, Marie JAROŠOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
      Name (in English): Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience
      RIV/00216224:14110/18:00104534 Conference abstract. English.
      Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Ďurechová, Kristina (203 Czech Republic, belonging to the institution) -- Freibergerová, Anna (203 Czech Republic, belonging to the institution) -- Jarošová, Marie (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: patients; CLL; aberrations; chemoimmunotherapy
      Changed by: Soňa Böhmová, učo 232884. Changed: 2/5/2019 14:24.
      More: https://is.muni.cz/publication/1469388/en
    6. Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii (Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line)
      ŠPUNAROVÁ, Michaela, Šárka PAVLOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Andrea BRZOBOHATÁ, Anna FREIBERGEROVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Genetické aberace a doba do progrese onemocnění u pacientů s CLL léčených režimy FCR nebo BR v 1. linii (Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line). In I. Český hematologický a transfuziologický sjezd, Praha. 2018.
      Name (in English): Genetic aberrations and time to disease progression in CLL patients treated with FCR or BR regimens in 1st line
      RIV/00216224:14110/18:00104061 Conference abstract. Czech.
      Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Brzobohatá, Andrea (203 Czech Republic, belonging to the institution) -- Freibergerová, Anna (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CLL; PCR; aberrations
      Changed by: Soňa Böhmová, učo 232884. Changed: 2/5/2019 14:11.
      More: https://is.muni.cz/publication/1450257/en
    7. Chronická lymfatická leukémie: převratné novinky v patogenezi a terapii z poslední doby
      DOUBEK, Michael, Jiří MAYER, Anna PANOVSKÁ, Yvona BRYCHTOVÁ and Šárka POSPÍŠILOVÁ. Chronická lymfatická leukémie: převratné novinky v patogenezi a terapii z poslední doby. In XIII. Brněnské hematologické dny/Novinky v hematologii, Brno. 2018.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 13/2/2019 10:59.
      More: https://is.muni.cz/publication/1496474/en
    8. Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling
      STRÁNSKÁ, Kamila, Karla PLEVOVÁ, Hana SKUHROVÁ FRANCOVÁ, Helena OLBERTOVÁ, Vasileios BIKOS, Hana JELÍNKOVÁ, Eva ZAPLETALOVÁ, Andrea MAREČKOVÁ, Jana KOTAŠKOVÁ, Boris TICHÝ, A. KOMKOV, G. NUGMANOV, Ilgar MAMEDOV, Tomáš REIGL, Nikos DARZENTAS, Hana ŠKABRAHOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Jiří MAYER, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling. In 23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere. 2018.
      Name (in English): Tracking the minor clones in oligoclonal chronic lymphocytic leukemia using high-throughput immunoprofiling
      RIV/00216224:14740/18:00104530 Conference abstract. English.
      Stránská, Kamila (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Olbertová, Helena (203 Czech Republic, belonging to the institution) -- Bikos, Vasileios (300 Greece, belonging to the institution) -- Jelínková, Hana (203 Czech Republic) -- Zapletalová, Eva (203 Czech Republic, belonging to the institution) -- Marečková, Andrea (203 Czech Republic) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Komkov, A. (643 Russian Federation) -- Nugmanov, G. (643 Russian Federation) -- Mamedov, Ilgar (643 Russian Federation) -- Reigl, Tomáš (203 Czech Republic, belonging to the institution) -- Darzentas, Nikos (300 Greece, belonging to the institution) -- Škabrahová, Hana (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: minor clones; CLL; oligoclonal; immunoprofiling
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 26/3/2019 15:39.
      More: https://is.muni.cz/publication/1469379/en
    9. Uvolnění buněk chronické lymfocytární leukemie z lymfatického systému do periferie po aplikaci rituximabu (Release of chronic lymphocytic leukemia cells from the lymphatic system to periphery after rituximab administration)
      BORSKÝ, Marek, J. NOVOTNÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Martin TRBUŠEK. Uvolnění buněk chronické lymfocytární leukemie z lymfatického systému do periferie po aplikaci rituximabu (Release of chronic lymphocytic leukemia cells from the lymphatic system to periphery after rituximab administration). In I. Český hematologický a transfuziologický sjezd, Praha in Transfuze a hematologie dnes. 2018.
      Name (in English): Release of chronic lymphocytic leukemia cells from the lymphatic system to periphery after rituximab administration
      RIV/00216224:14110/18:00106944 Conference abstract. Czech.
      Borský, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: CLL; rituximab
      Changed by: Soňa Böhmová, učo 232884. Changed: 2/5/2019 14:19.
      More: https://is.muni.cz/publication/1462457/en

    2017

    1. Alogenní transplantace po režimu s redukovanou intenzitou u 25 pacientů s vysoce rizikovou chronickou lymfatickou leukémií
      KREJČÍ, Marta, Michael DOUBEK, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Miroslav TOMÍŠKA, Blanka ROBEŠOVÁ and Jiří MAYER. Alogenní transplantace po režimu s redukovanou intenzitou u 25 pacientů s vysoce rizikovou chronickou lymfatickou leukémií. In XXXI. Olomoucké hematologické dny, Olomouc. 2017.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 22/6/2017 21:57.
      More: https://is.muni.cz/publication/1383734/en
    2. Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency
      PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Jana KOTAŠKOVÁ, Lucie POPPOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Kristina ĎURECHOVÁ, Alexandra OLTOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency. In 22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica (2017). 2017.
      Name (in English): Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency
      RIV/00216224:14740/17:00099490 Conference abstract. Oncology and haematology. English.
      Plevová, Karla (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Poppová, Lucie (203 Czech Republic, belonging to the institution) -- Šmardová, Jana (203 Czech Republic) -- Divíšková, Eva (203 Czech Republic) -- Ďurechová, Kristina (203 Czech Republic) -- Oltová, Alexandra (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic) -- Panovská, Anna (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: TP53; heterozygosity; mutations
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 17/5/2018 14:12.
      More: https://is.muni.cz/publication/1404122/en
    3. Dopad rekurentních mutací na dobu do progrese po terapiích zahrnujících rituximab v 1. linii u pacientů s CLL. (Impact of recurrent mutations over time to progression following rituximab first line therapy in patients with CLL)
      HLOŽKOVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Eva DIVÍŠKOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Dopad rekurentních mutací na dobu do progrese po terapiích zahrnujících rituximab v 1. linii u pacientů s CLL. (Impact of recurrent mutations over time to progression following rituximab first line therapy in patients with CLL). In XXXI. Olomoucké hematologické dny. 2017.
      Name (in English): Impact of recurrent mutations over time to progression following rituximab first line therapy in patients with CLL
      RIV/00216224:14110/17:00096949 Conference abstract. Czech.
      Hložková, Michaela (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Divíšková, Eva (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution)
      Keywords in English: progression; CLL; therapy
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 14/2/2018 13:59.
      More: https://is.muni.cz/publication/1383036/en
    4. Chronická lymfocytární leukemie (Chronic lymphocytic leukemia)
      PANOVSKÁ, Anna, Yvona BRYCHTOVÁ and Michael DOUBEK. Chronická lymfocytární leukemie (Chronic lymphocytic leukemia). In Tomáš Büchler a kolektiv. Speciální onkologie. Praha: Maxdorf, 2017, p. 167-171. Jessenius. ISBN 978-80-7345-539-2.
      URL
      Name (in English): Chronic lymphocytic leukemia
      RIV/00216224:14110/17:00099736 Chapter(s) of a specialized book. Oncology and haematology. Czech. Czech Republic.
      Panovská, Anna (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; prognostic factors; chemoimmunotherapy; BCR signalling inhibitors
      Changed by: Soňa Böhmová, učo 232884. Changed: 18/3/2018 17:46.
      More: https://is.muni.cz/publication/1405740/en
    5. Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.
      ŠPUNAROVÁ, Michaela, Jitka MALČÍKOVÁ, Nikola TOM, Marek BORSKÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Anna PANOVSKÁ, Eva DIVÍŠKOVÁ, Marek MRÁZ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Martin TRBUŠEK. Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens. In 22nd congress of EHA, Madrid, Španělsko, červen 2017 in Haematologica (2017). 2017.
      Name (in English): Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.
      RIV/00216224:14110/17:00099492 Conference abstract. Oncology and haematology. English.
      Špunarová, Michaela (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Divíšková, Eva (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution)
      Keywords in English: recurrent mutations; CLL; impact
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 9/2/2018 21:18.
      More: https://is.muni.cz/publication/1404136/en
    6. Leukemie z vlasatých buněk (Hairy cell leukemia)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Leukemie z vlasatých buněk (Hairy cell leukemia). In Tomáš Büchler a kolektiv. Speciální onkologie. Praha: Maxdorf, 2017, p. 184-188. Jessenius. ISBN 978-80-7345-539-2.
      URL
      Name (in English): Hairy cell leukemia
      RIV/00216224:14110/17:00099734 Chapter(s) of a specialized book. Oncology and haematology. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: hairy cell leukemia; classic form; BRAF V600E mutation; cladribine
      Changed by: Soňa Böhmová, učo 232884. Changed: 18/3/2018 17:48.
      More: https://is.muni.cz/publication/1405730/en
    7. Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine
      ŠPAČEK, M., P. OBRTLÍKOVÁ, Markéta HADRABOVÁ, Eduard CMUNT, J. KARBAN, J. MOLINSKÝ, M. SIMKOVIC, Heidi MÓCIKOVÁ, L. MOHAMMADOVA, Anna PANOVSKÁ, J. NOVÁK, Lukáš SMOLEJ, Michael DOUBEK and Marek TRNĚNÝ. Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine. In XVII International Workshop on Chronic Lymphocytic Leukemia. 2017.
      Name (in English): Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine
      RIV/00216224:14110/17:00099491 Conference abstract. English.
      Špaček, M. (203 Czech Republic) -- Obrtlíková, P. (203 Czech Republic) -- Hadrabová, Markéta (203 Czech Republic, belonging to the institution) -- Cmunt, Eduard (203 Czech Republic) -- Karban, J. (203 Czech Republic) -- Molinský, J. (203 Czech Republic) -- Simkovic, M. (203 Czech Republic) -- Móciková, Heidi (703 Slovakia, belonging to the institution) -- Mohammadova, L. (203 Czech Republic) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Novák, J. (203 Czech Republic) -- Smolej, Lukáš (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Trněný, Marek (203 Czech Republic)
      Keywords in English: observational; CLL; study
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 14/2/2018 14:58.
      More: https://is.muni.cz/publication/1404124/en
    8. Prolymfocytární leukemie (Prolymphocytic leukemia)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Prolymfocytární leukemie (Prolymphocytic leukemia). In Tomáš Büchler a kolektiv. Speciální onkologie. Praha: Maxdorf, 2017, p. 178-183. Jessenius. ISBN 978-80-7345-539-2.
      URL
      Name (in English): Prolymphocytic leukemia
      RIV/00216224:14110/17:00099735 Chapter(s) of a specialized book. Oncology and haematology. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: prolymphocytic leukemia; TP53 gene; treatment; alemtuzumab
      Changed by: Soňa Böhmová, učo 232884. Changed: 18/3/2018 17:42.
      More: https://is.muni.cz/publication/1405732/en
    9. Tracking Low-Burden TP53-mutated subclones during CLL treatment and remission using ROR1 separation
      MALČÍKOVÁ, Jitka, Jana KOTAŠKOVÁ, Šárka PAVLOVÁ, Nikola TOM, Karol PÁL, Anna PANOVSKÁ, Yvona BRYCHTOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Tracking Low-Burden TP53-mutated subclones during CLL treatment and remission using ROR1 separation. In XVII International Workshop on Chronic Lymphocytic Leukemia. 2017.
      Name (in English): Tracking Low-Burden TP53-mutated subclones during CLL treatment and remission using ROR1 separation
      RIV/00216224:14740/17:00095698 Conference abstract. English.
      Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Kotašková, Jana (203 Czech Republic, belonging to the institution) -- Pavlová, Šárka (203 Czech Republic, belonging to the institution) -- Tom, Nikola (203 Czech Republic, belonging to the institution) -- Pál, Karol (703 Slovakia, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: TP53; CLL; subclones
      Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 28/3/2018 10:47.
      More: https://is.muni.cz/publication/1404146/en

    2016

    1. Chronická lymfocytární leukemie : Informace pro pacienty a jejich blízké (Chronic lymphocytic leukemia : Information for patients and their relatives)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ and Michael DOUBEK. Chronická lymfocytární leukemie : Informace pro pacienty a jejich blízké (Chronic lymphocytic leukemia : Information for patients and their relatives). První vydání. Brno: Pro Českou leukemickou skupinu - pro život (CELL) vydalo nakladatelství Kmen, spol. s.r.o., 2016, 38 pp. ISBN 978-80-906212-5-1.
      Name (in English): Chronic lymphocytic leukemia : Information for patients and their relatives
      RIV/00216224:14110/16:00092583 Survey and educational texts. Oncology and haematology. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; management; patient; relative
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 3/1/2017 08:38.
      More: https://is.muni.cz/publication/1366226/en
    2. Rare recurrent chromosomal abnormalities in CLL detected by conventional cytogenetics after stimulation with CpG-ODN and IL-2 and fish
      STOKLASOVÁ, M., H. KUCHAROVA, A. BURDOVA, B. DREVOJANKOVA, T. SABLATUROVA, A. STRNKOVA, L. TRUHLIKOVA, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Karla PLEVOVÁ, Alexandra OLTOVÁ, N. RYTIKOVA, N. PETRICOVA, Dagmar ADAMOVÁ, V. HEINZOVÁ, I. ZYGULOVÁ, J. LASKA, J. ZUCHNICKA, C. BODZASOVA, J. DURAS, M. URBÁNKOVÁ, Z. JEHLÍKOVÁ, P. SLEZÁK, J. MACUROVÁ, D. JANEK, E. BOGOCZOVÁ, M. WROBEL, D. KLODOVA, Z. ZETKOVÁ and Martin BREJCHA. Rare recurrent chromosomal abnormalities in CLL detected by conventional cytogenetics after stimulation with CpG-ODN and IL-2 and fish. In Haematologica (2016); 101(s1): 717 (21st Congress of the EHA). 2016.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 8/12/2016 12:43.
      More: https://is.muni.cz/publication/1364052/en

    2015

    1. Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study
      DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Ludmila ŠEBEJOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Karla PLEVOVÁ, Pavlína VOLFOVÁ, Martin TRBUŠEK, Marek MRÁZ, Denisa BAKEŠOVÁ, Jakub TRIZULJAK, Markéta HADRABOVÁ, Petra OBRTLÍKOVÁ, Josef KARBAN, Lukáš SMOLEJ, Alexandra OLTOVÁ, Eva JELÍNKOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. American Journal of Hematology. Hoboken: Wiley-Blackwell, 2015, vol. 90, No 5, p. 417-421. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.23964.
      URL
      RIV/00216224:14740/15:00082873 Article in a journal. Oncology and haematology. English. United States of America.
      Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic) -- Panovská, Anna (203 Czech Republic) -- Šebejová, Ludmila (203 Czech Republic) -- Stehlíková, Olga (203 Czech Republic) -- Chovancová, Jana (203 Czech Republic) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Šmardová, Jana (203 Czech Republic) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Volfová, Pavlína (203 Czech Republic) -- Trbušek, Martin (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Bakešová, Denisa (703 Slovakia) -- Trizuljak, Jakub (703 Slovakia) -- Hadrabová, Markéta (203 Czech Republic) -- Obrtlíková, Petra (203 Czech Republic) -- Karban, Josef (203 Czech Republic) -- Smolej, Lukáš (203 Czech Republic) -- Oltová, Alexandra (203 Czech Republic) -- Jelínková, Eva (203 Czech Republic) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: HIGH-DOSE METHYLPREDNISOLONE; RITUXIMAB; COMBINATION; FLUDARABINE; IBRUTINIB; EFFICACY; THERAPY; CD20
      International impact: yes
      Reviewed: yes
      Changed by: Martina Prášilová, učo 342282. Changed: 23/12/2015 08:58.
      More: https://is.muni.cz/publication/1299395/en

    2014

    1. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis.
      BREJCHA, Martin, Martina STOKLASOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Kristina ŠTĚPANOVSKÁ, Gabriela VAŇKOVÁ, Karla PLEVOVÁ, Alexandra OLTOVÁ, Kateřina HORKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis. Leukemia Research. Oxford: Pergamon Elsevier, 2014, vol. 38, No 2, p. 170-175. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2013.10.019.
      URL
      Name (in English): Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis.
      RIV/00216224:14740/14:00074868 Article in a journal. Oncology and haematology. English. United Kingdom of Great Britain and Northern Ireland.
      Brejcha, Martin (203 Czech Republic) -- Stoklasová, Martina (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Štěpanovská, Kristina (203 Czech Republic, belonging to the institution) -- Vaňková, Gabriela (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Oltová, Alexandra (203 Czech Republic, belonging to the institution) -- Horká, Kateřina (203 Czech Republic) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: Chronic lymphocytic leukemia; Clonal evolution; CpG oligonucleotides; Cytogenetics; Fluorescence in situ hybridization; Interleukin-2
      International impact: yes
      Reviewed: yes
      Changed by: Martina Prášilová, učo 342282. Changed: 28/4/2015 11:03.
      More: https://is.muni.cz/publication/1138698/en
    2. Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
      STEHLÍKOVÁ, Olga, Jana CHOVANCOVÁ, Boris TICHÝ, Marta KREJČÍ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Kateřina BURČKOVÁ, Marek BORSKÝ, Tomáš LOJA, Jiří MAYER, Šárka POSPÍŠILOVÁ and Michael DOUBEK. Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice. International Journal of Laboratory Hematology. Hoboken (USA): Blackwell Scientific Publications, 2014, vol. 36, No 2, p. 165-171. ISSN 1751-5521. Available from: https://dx.doi.org/10.1111/ijlh.12149.
      URL
      Name (in English): Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
      RIV/00216224:14740/14:00074835 Article in a journal. Oncology and haematology. English. United States of America.
      Stehlíková, Olga (203 Czech Republic, belonging to the institution) -- Chovancová, Jana (203 Czech Republic, belonging to the institution) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Krejčí, Marta (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Skuhrová Francová, Hana (203 Czech Republic, belonging to the institution) -- Burčková, Kateřina (203 Czech Republic, belonging to the institution) -- Borský, Marek (203 Czech Republic, belonging to the institution) -- Loja, Tomáš (703 Slovakia, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, guarantor, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: CELL; CLL; FLUDARABINE; DIAGNOSIS; SURVIVAL; TRIAL
      International impact: yes
      Reviewed: yes
      Changed by: Martina Prášilová, učo 342282. Changed: 28/4/2015 10:59.
      More: https://is.muni.cz/publication/1131973/en

    2013

    1. Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life
      DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, J. TRIZULJAK, Ludmila ŠEBEJOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Karla PLEVOVÁ, Pavlína VOLFOVÁ, Martin TRBUŠEK, Marek MRÁZ, Denisa MAJERČÁKOVÁ, Petra OBRTLÍKOVÁ, Josef KARBAN, Lukáš SMOLEJ, Michaela LINDTNEROVÁ, Alexandra OLTOVÁ, Eva JELÍNKOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life. In 55th ASH Annual Meeting and Exposition. 2013.
      Oncology and haematology. English. United States of America.
      International impact: yes
      Reviewed: yes
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 3/1/2014 10:54.
      More: https://is.muni.cz/publication/1138569/en
    2. The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab
      PANOVSKÁ, Anna, L. SMOLEJ, D. LYSÁK, Yvona BRYCHTOVÁ, M. ŠIMKOVIČ, M. MOTYČKOVÁ, P. VODÁREK, Michaela LINDTNEROVÁ, Martin TRBUŠEK, Jitka MALČÍKOVÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab. European Journal of Haematology. Kopenhagen: Wiley-Blackwell, Munksgaard Int. Publ. Ltd., 2013, vol. 90, No 6, p. 479-485. ISSN 0902-4441. Available from: https://dx.doi.org/10.1111/ejh.12106.
      RIV/00216224:14740/13:00065583 Article in a journal. Oncology and haematology. English. Denmark.
      Panovská, Anna (203 Czech Republic, belonging to the institution) -- Smolej, L. (203 Czech Republic) -- Lysák, D. (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Šimkovič, M. (203 Czech Republic) -- Motyčková, M. (203 Czech Republic) -- Vodárek, P. (203 Czech Republic) -- Lindtnerová, Michaela (203 Czech Republic, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: chronic lymhocytic leukemia; FRC chemoimmunotherapy; relapse; survival
      International impact: yes
      Reviewed: yes
      Changed by: Olga Křížová, učo 56639. Changed: 3/4/2014 04:24.
      More: https://is.muni.cz/publication/1095488/en

    2012

    1. Febrilní pancytopenie a hepatosplenomegalie jako hlavní symptomy viscerální leishmaniózy. (Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis)
      POLÁK, Pavel, Radek SVOBODA, Petra KUBÁČKOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Eva NOHÝNKOVÁ, Petr HUSA, Michaela FREIBERGEROVÁ, Radana PAŘÍZKOVÁ, Marta ŠNELEROVÁ, Martina PÝCHOVÁ and Jan KAMELANDER. Febrilní pancytopenie a hepatosplenomegalie jako hlavní symptomy viscerální leishmaniózy. (Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis). Vnitřní lékařství. Praha: Česká lékařská společnost JEP, 2012, vol. 58, No 10, p. 761-764. ISSN 0042-773X.
      Name (in English): Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis
      RIV/00216224:14110/12:00061559 Article in a journal. Epidemiology, infection diseases and clinical immunology. Czech. Czech Republic.
      Polák, Pavel (203 Czech Republic, guarantor, belonging to the institution) -- Svoboda, Radek (203 Czech Republic) -- Kubáčková, Petra (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic) -- Panovská, Anna (203 Czech Republic) -- Nohýnková, Eva (203 Czech Republic) -- Husa, Petr (203 Czech Republic) -- Freibergerová, Michaela (203 Czech Republic) -- Pařízková, Radana (203 Czech Republic) -- Šnelerová, Marta (203 Czech Republic) -- Pýchová, Martina (203 Czech Republic) -- Kamelander, Jan (203 Czech Republic)
      Keywords in English: visceral leishmaniasis; pancytopenia; hepatosplenomegaly; amphothericin B; miltefosin
      International impact: yes
      Reviewed: yes
      Changed by: prof. MUDr. Petr Husa, CSc., učo 945. Changed: 29/10/2012 07:58.
      More: https://is.muni.cz/publication/1071089/en
    2. Hematologická onkologie : leukemie a lymfomy v humánní medicíně (Hematological oncology : leukemia and lymphoma in human medicine)
      DOUBEK, Michael, František FOLBER, Andrea JANÍKOVÁ, Anna PANOVSKÁ, David ŠÁLEK and Martina TOŠKOVÁ. Hematologická onkologie : leukemie a lymfomy v humánní medicíně (Hematological oncology : leukemia and lymphoma in human medicine). Brno: Veterinární a farmaceutická univerzita, 2012, 128 pp. ISBN 978-80-7305-621-6.
      Name (in English): Hematological oncology : leukemia and lymphoma in human medicine
      RIV/00216224:14110/12:00060522 Book on a specialized topic. Oncology and haematology. Czech. Czech Republic.
      Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution) -- Folber, František (203 Czech Republic, belonging to the institution) -- Janíková, Andrea (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Šálek, David (203 Czech Republic, belonging to the institution) -- Tošková, Martina (703 Slovakia, belonging to the institution)
      Keywords in English: leukemia; lymphoma; diagnostics; therapy; human medicine
      Reviewed: yes
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 8/4/2013 17:56.
      More: https://is.muni.cz/publication/988325/en
    3. Léčba chronické lymfocytární leukemie (Treatment of chronic lymphocytic leukaemia)
      DOUBEK, Michael and Anna PANOVSKÁ. Léčba chronické lymfocytární leukemie (Treatment of chronic lymphocytic leukaemia). Farmakoterapie. 2012, vol. 8, No 3, p. 265-274. ISSN 1801-1209.
      Name (in English): Treatment of chronic lymphocytic leukaemia
      RIV/00216224:14110/12:00060248 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukaemia; prognostic factors; chemoimmunotherapy; allogeneic stem cell transplantation
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 20/6/2012 14:08.
      More: https://is.muni.cz/publication/985485/en
    4. Onkologie (Oncology)
      VORLÍČEK, Jiří, Jitka ABRAHÁMOVÁ, Viera BAJČIOVÁ, Tomáš BÜCHLER, Michael DOUBEK, František FOLBER, Anna PANOVSKÁ, Zdeněk RÁČIL, Petr SZTURZ, Martina TOŠKOVÁ and Karel ZITTERBART. Onkologie (Oncology). Vyd. 1. Praha: Triton, 2012, 250 pp. Lékařské repetitorium ; sv. č. 7. ISBN 978-80-7387-603-6.
      URL
      Name (in English): Oncology
      RIV/00216224:14110/12:00063723 Book on a specialized topic. Oncology and haematology. Czech. Czech Republic.
      Vorlíček, Jiří (203 Czech Republic, guarantor) -- Abrahámová, Jitka (203 Czech Republic) -- Bajčiová, Viera (703 Slovakia, belonging to the institution) -- Büchler, Tomáš (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Folber, František (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Ráčil, Zdeněk (203 Czech Republic, belonging to the institution) -- Szturz, Petr (203 Czech Republic, belonging to the institution) -- Tošková, Martina (203 Czech Republic) -- Zitterbart, Karel (203 Czech Republic, belonging to the institution)
      Keywords in English: cancer; solid tumors; leukemia; lymphoma; myeloma; therapy
      Reviewed: yes
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 8/4/2013 18:29.
      More: https://is.muni.cz/publication/1086568/en
    5. Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
      SMOLEJ, Lukáš, Michael DOUBEK, Anna PANOVSKÁ, Martin ŠIMKOVIČ, Yvona BRYCHTOVÁ, David BELADA, Monika MOTYČKOVÁ and Jiří MAYER. Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia. Leukemia Research. Oxford, UK: PERGAMON-ELSEVIER SCIENCE LTD, 2012, vol. 36, No 10, p. 1278-1282. ISSN 0145-2126. Available from: https://dx.doi.org/10.1016/j.leukres.2012.07.005.
      URL
      RIV/00216224:14740/12:00065566 Article in a journal. Oncology and haematology. English. United Kingdom of Great Britain and Northern Ireland.
      Smolej, Lukáš (203 Czech Republic, guarantor) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Šimkovič, Martin (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Belada, David (203 Czech Republic) -- Motyčková, Monika (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: Chronic lymphocytic leukemia Rituximab Dexamethasone Refractory disease Chemoimmunotherapy Corticosteroids
      International impact: yes
      Reviewed: yes
      Changed by: Olga Křížová, učo 56639. Changed: 20/3/2014 13:36.
      More: https://is.muni.cz/publication/989192/en
    6. Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia
      DOUBEK, Michael, Martin TRBUŠEK, Jitka MALČÍKOVÁ, Yvona BRYCHTOVÁ, Jana ŠMARDOVÁ, Jana LOCHMANOVÁ, Anna PANOVSKÁ, Hana FRANCOVÁ, Marek MRÁZ, Boris TICHÝ, Ludmila ŠEBEJOVÁ, Veronika NAVRKALOVÁ, Karla PLEVOVÁ, Petr KUGLÍK, Jiří MAYER and Šárka POSPÍŠILOVÁ. Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia. Leukemia & Lymphoma. LONDON: INFORMA HEALTHCARE, 2012, vol. 53, No 9, p. 1817-1819. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2012.658794.
      URL
      RIV/00216224:14740/12:00062071 Article in a journal. Oncology and haematology. English. United Kingdom of Great Britain and Northern Ireland.
      Doubek, Michael (203 Czech Republic, guarantor, belonging to the institution) -- Trbušek, Martin (203 Czech Republic, belonging to the institution) -- Malčíková, Jitka (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Šmardová, Jana (203 Czech Republic, belonging to the institution) -- Lochmanová, Jana (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Francová, Hana (203 Czech Republic, belonging to the institution) -- Mráz, Marek (203 Czech Republic, belonging to the institution) -- Tichý, Boris (203 Czech Republic, belonging to the institution) -- Šebejová, Ludmila (203 Czech Republic, belonging to the institution) -- Navrkalová, Veronika (203 Czech Republic, belonging to the institution) -- Plevová, Karla (203 Czech Republic, belonging to the institution) -- Kuglík, Petr (203 Czech Republic, belonging to the institution) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Pospíšilová, Šárka (203 Czech Republic, belonging to the institution)
      Keywords in English: chronic lymphocytic leukemia; p53 mutation; alemtuzumab
      International impact: yes
      Changed by: Olga Křížová, učo 56639. Changed: 12/4/2013 10:12.
      More: https://is.muni.cz/publication/1075198/en

    2011

    1. Chronická B-lymfocytární leukémie (Chronic B-lymphocytic leukemia)
      PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Jiří MAYER and Michael DOUBEK. Chronická B-lymfocytární leukémie (Chronic B-lymphocytic leukemia). Postgraduální medicína. 2011, vol. 13, No 3, p. 294-301. ISSN 1212-4184.
      Name (in English): Chronic B-lymphocytic leukemia
      RIV/00216224:14110/11:00054649 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Panovská, Anna (203 Czech Republic, guarantor, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: epidemiology; chemoimmunotherapy; chronic lymphocytic leukemia; prognostic factors
      Reviewed: yes
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 2/1/2012 16:09.
      More: https://is.muni.cz/publication/964395/en
    2. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.
      PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Gabriela VAŇKOVÁ, Boris TICHÝ, Šárka POSPÍŠILOVÁ, Jiří MAYER and Michael DOUBEK. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment. In 16th Congress of the European Hematology Association in Haematologica - the hematology journal. 2011. ISSN 0390-6078.
      Oncology and haematology. English. Czech Republic.
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 2/12/2011 07:51.
      More: https://is.muni.cz/publication/960241/en
    3. The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients
      DOUBEK, Michael, Martin TRBUŠEK, Jitka MALČÍKOVÁ, Yvona BRYCHTOVÁ, Jana ŠMARDOVÁ, Jana LOCHMANOVÁ, Anna PANOVSKÁ, Hana SKUHROVÁ FRANCOVÁ, Marek MRÁZ, Boris TICHÝ, Ludmila ŠEBEJOVÁ, Petr DOBEŠ, Karla PLEVOVÁ, Gabriela VAŇKOVÁ, Petr KUGLÍK, Jiří MAYER and Šárka POSPÍŠILOVÁ. The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients. In XIV. International workshop on chronic lymphocytic leukemia in Clinical Lymphoma, Myeloma and Leukemia. 2011. ISSN 2152-2650.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 15/1/2012 21:42.
      More: https://is.muni.cz/publication/966239/en
    4. The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients
      DOUBEK, Michael, Jitka MALČÍKOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Petr KOZMON, Petr DOBEŠ, Gabriela VAŇKOVÁ, Jana ŠMARDOVÁ, Petr KUGLÍK, Marek MRÁZ, Boris TICHÝ, Ludmila ŠEBEJOVÁ, Jiří MAYER, Martin TRBUŠEK and Šárka POSPÍŠILOVÁ. The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients. In 16th Congress of the European Hematology Association in Haematologica - the hematology journal. 2011. ISSN 0390-6078.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 4/12/2011 11:09.
      More: https://is.muni.cz/publication/960308/en
    5. Vlasatobuněčná leukémie (Hairy cell leukemia)
      BRYCHTOVÁ, Yvona, Anna PANOVSKÁ, Petr KOZMON and Michael DOUBEK. Vlasatobuněčná leukémie (Hairy cell leukemia). Postgraduální medicína. 2011, vol. 13, No 3, p. 309-315. ISSN 1212-4184.
      Name (in English): Hairy cell leukemia
      RIV/00216224:14110/11:00054650 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Brychtová, Yvona (203 Czech Republic, guarantor) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Kozmon, Petr (203 Czech Republic) -- Doubek, Michael (203 Czech Republic, belonging to the institution)
      Keywords in English: cladribine; hairy cell leukemia; immunoconjugates; kladribin; pentostatin; rituximab
      Reviewed: yes
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 2/1/2012 16:14.
      More: https://is.muni.cz/publication/964397/en
    6. Výsledky recentních velkých randomizovaných studií léčby CLL.
      DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Výsledky recentních velkých randomizovaných studií léčby CLL. In VI. Brněnské hematologické dny. 2011.
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 10/1/2012 21:23.
      More: https://is.muni.cz/publication/965653/en

    2010

    1. Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.
      FIEGL, M., M. ERDEL, I. TINHOFER, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, K. EIGENBERGER, C. FONATSCH, G. HOPFINGER, H. MÜHLBERGER, A. ZABERNIGG, F. FALKNER, G. GASTL, Jiří MAYER and R. GREIL. Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Annals of Oncology. 2010, vol. 21, No 12, p. 2410-2419. ISSN 0923-7534. Available from: https://dx.doi.org/10.1093/annonc/mdq236.
      RIV/00216224:14110/10:00051755 Article in a journal. Oncology and haematology. English. United Kingdom of Great Britain and Northern Ireland.
      Fiegl, M. (40 Austria, guarantor) -- Erdel, M. (40 Austria) -- Tinhofer, I. (40 Austria) -- Brychtová, Yvona (203 Czech Republic, belonging to the institution) -- Panovská, Anna (203 Czech Republic, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Eigenberger, K. (40 Austria) -- Fonatsch, C. (40 Austria) -- Hopfinger, G. (40 Austria) -- Mühlberger, H. (40 Austria) -- Zabernigg, A. (40 Austria) -- Falkner, F. (40 Austria) -- Gastl, G. (40 Austria) -- Mayer, Jiří (203 Czech Republic, belonging to the institution) -- Greil, R. (40 Austria)
      Keywords in English: alemtuzumab; chronic lymphocytic leukemia; cytogenetic abnormalities; FISH
      International impact: yes
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 12/4/2012 16:07.
      More: https://is.muni.cz/publication/921538/en
    2. Co víme o incidenci chronické lymfocytární leukemie (CLL), a kde a jak jsou nemocní s CLL léčeni? (What we know about the incidence of CLL and where and how they treated patients with CLL?)
      DOUBEK, Michael, Anna PANOVSKÁ, J. JANČA, L. JUDÁSKOVÁ, I. MELUZÍNOVÁ, N. HEJLOVÁ, R. BARTOŠOVÁ, J. SIMONIDES, P. JAJTNER, A. GAJA, L. INGROVÁ, M. MAŠKOVÁ, H. VESELÁ, J. PEPRLA, L. PRAŽÁKOVÁ, M. ZVAROVÁ, E. KRAHULCOVÁ, A. BULIKOVÁ, I. ŠEVČÍKOVÁ, V. DOSTÁLOVÁ, Yvona BRYCHTOVÁ and Jiří MAYER. Co víme o incidenci chronické lymfocytární leukemie (CLL), a kde a jak jsou nemocní s CLL léčeni? (What we know about the incidence of CLL and where and how they treated patients with CLL?). Transfuze a Hematologie dnes. 2010, vol. 16, No 1, p. 11-15. ISSN 1213-5763.
      Name (in English): What we know about the incidence of CLL and where and how they treated patients with CLL?
      RIV/00216224:14110/10:00040777 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Doubek, Michael (203 Czech Republic, guarantor) -- Panovská, Anna (203 Czech Republic) -- Janča, J. (203 Czech Republic) -- Judásková, L. (203 Czech Republic) -- Meluzínová, I. (203 Czech Republic) -- Hejlová, N. (203 Czech Republic) -- Bartošová, R. (203 Czech Republic) -- Simonides, J. (203 Czech Republic) -- Jajtner, P. (203 Czech Republic) -- Gaja, A. (203 Czech Republic) -- Ingrová, L. (203 Czech Republic) -- Mašková, M. (203 Czech Republic) -- Veselá, H. (203 Czech Republic) -- Peprla, J. (203 Czech Republic) -- Pražáková, L. (203 Czech Republic) -- Zvarová, M. (203 Czech Republic) -- Krahulcová, E. (203 Czech Republic) -- Buliková, A. (203 Czech Republic) -- Ševčíková, I. (203 Czech Republic) -- Dostálová, V. (203 Czech Republic) -- Brychtová, Yvona (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic)
      Keywords in English: chronic lymphocytic leukemia; epidemiology; treatment
      Changed by: Jitka Firešová, učo 112925. Changed: 13/8/2010 10:52.
      More: https://is.muni.cz/publication/891249/en
    3. Epidemiologie chronické lymfocytární leukemie (CLL), aneb kde končí monoklonální B lymfocytóza a začíná CLL.
      DOUBEK, Michael and Anna PANOVSKÁ. Epidemiologie chronické lymfocytární leukemie (CLL), aneb kde končí monoklonální B lymfocytóza a začíná CLL. 2010. ISSN 1213-5763.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 8/10/2012 20:54.
      More: https://is.muni.cz/publication/891713/en
    4. Chronic Lymphocytic Leukemia and Focusing on Epidemiology and Management in Everyday Hematologic Practice: Recent Data From the Czech Leukemia Study Group for Life (CELL)
      PANOVSKÁ, Anna, Michael DOUBEK, Yvona BRYCHTOVÁ and Jiří MAYER. Chronic Lymphocytic Leukemia and Focusing on Epidemiology and Management in Everyday Hematologic Practice: Recent Data From the Czech Leukemia Study Group for Life (CELL). Clinical Lymphoma, Myeloma & Leukemia. 2010, vol. 10, No 4, p. 297-300. ISSN 2152-2650.
      Name in Czech: Chronická lymfatická leukemie Epidemiologie a léčba pacientů s touto diagnózou v každodenní lékařské praxi: Aktuální data České leukemické - pro život (CELL)
      RIV/00216224:14110/10:00045320 Article in a journal. Oncology and haematology. English. United States of America.
      Panovská, Anna (203 Czech Republic, guarantor, belonging to the institution) -- Doubek, Michael (203 Czech Republic, belonging to the institution) -- Brychtová, Yvona (203 Czech Republic) -- Mayer, Jiří (203 Czech Republic, belonging to the institution)
      Keywords in English: Alemtuzumab;Cyclophosphamide;Doxorubicin; Prednisolone; Prednisone; Vincristine
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 6/2/2019 10:48.
      More: https://is.muni.cz/publication/906610/en
    5. Rituximab in combination with high-dose dexamethasone: an effective treatment option for patients with relapsed/refractory chronic lymphocytic leukemia
      SIMKOVIC, M., Anna PANOVSKÁ, D. BELADA, M. HRUDKOVÁ, Yvona BRYCHTOVÁ, Jiří MAYER, L. SMOLEJ and Michael DOUBEK. Rituximab in combination with high-dose dexamethasone: an effective treatment option for patients with relapsed/refractory chronic lymphocytic leukemia. In Haematologica, 15th Congress of teh European hematology association, Barcelona, Spain. 2010. ISSN 0390-6078.
      Oncology and haematology. English. Czech Republic.
      International impact: yes
      Reviewed: yes
      Changed by: RNDr. Jitka Malčíková, Ph.D., učo 14364. Changed: 5/8/2010 09:55.
      More: https://is.muni.cz/publication/893172/en
    6. Rituximab v kombinaci s vysokodávkovaným Dexamethasonem: efektivní léčebná modalita u pacientů s relabující/refrakterní chronickou lymfocytární leukemií.
      PANOVSKÁ, Anna, Martin ŠIMKOVIČ, David BELADA, Monika HRUDKOVÁ, Lukáš SMOLEJ, Jiří MAYER and Michael DOUBEK. Rituximab v kombinaci s vysokodávkovaným Dexamethasonem: efektivní léčebná modalita u pacientů s relabující/refrakterní chronickou lymfocytární leukemií. 2010. ISSN 1213-5763.
      Oncology and haematology. Czech. Czech Republic.
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 8/10/2012 20:55.
      More: https://is.muni.cz/publication/891721/en

    2009

    1. Rituximab in combination with dexamethasone or high-dose methylprednisolone in refractory chronic lymphocytic leukemia
      DOUBEK, Michael, L SMOLEJ, Anna PANOVSKÁ, Yvona BRYCHTOVÁ and Jiří MAYER. Rituximab in combination with dexamethasone or high-dose methylprednisolone in refractory chronic lymphocytic leukemia. Haematologica. 2009, vol. 94, No 3, p. 67. ISSN 0390-6078.
      Oncology and haematology. English.
      Changed by: Jitka Firešová, učo 112925. Changed: 22/2/2010 12:13.
      More: https://is.muni.cz/publication/873035/en

    2007

    1. Importance of Monitoring the Quality of Care of Patients with Febrile Neutropenia
      SVOBODA, Marek, Miloš HOLÁNEK, Eva KONEČNÁ, Mária ZVARÍKOVÁ, Miloš CHOBOLA, Jiří NAVRÁTIL, Lenka BEŇADIKOVÁ, Anna FIALOVÁ, Jana KLEINOVÁ and Rostislav VYZULA. Importance of Monitoring the Quality of Care of Patients with Febrile Neutropenia. In Supportive Care in Cancer : Abstracts of the 20th Anniversary International MASCC/ISOO Symposium. 2007. ISSN 0941-4355.
      Name in Czech: Význam monitorace kvality péče o pacienty s febrilní neutropenií.
      Name (in English): Importance of Monitoring the Quality of Care of Patients with Febrile Neutropenia
      Oncology and haematology. English. Germany.
      Keywords in English: febrile neutropenia;qulity of care;chemotherapy;G-CSF;relative dose intensity
      International impact: yes
      Changed by: Mgr. Michal Petr, učo 65024. Changed: 6/4/2012 12:26.
      More: https://is.muni.cz/publication/746076/en
Displayed: 25/5/2024 18:19